Answers are grounded in this paper and cite their sources.
A mutasynthetic strategy has been used to generate fluorinated TM-025 and TM-026, two biosynthetically engineered pactamycin analogues produced by Streptomyces pactum ATCC 27456. The fluorinated compounds maintain excellent activity and selectivity toward chloroquine-sensitive and multidrug-resistant strains of malarial parasites as the parent compounds. The results also provide insights into the biosynthesis of 3-aminobenzoic acid in S. pactum.
No takes yet. Share an insight, caveat, or question.
Almabruk et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: